Clinical Trial Update: Dose Finding Study of Il-2 at Ultra-low Dose in Children With Recently Diagnosed Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 dose-finding trial of ultra-low-dose IL-2 in children with newly diagnosed Type 1 Diabetes completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• IL-2 (Interleukin-2)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED